Table 4

Diagnosis and first-line treatment among different respondent groups. X2 test is used for the group comparison. Statistically significant difference (p<0.05) appear in bold

Anaphylaxis diagnosis OR 95% CIp ValueIntramuscular adrenalin OR 95% CIp ValuePrednisolone OR 95% CIp ValueChloropyramine OR 95% CIp Value
Sex0.75 (0.36 to 1.57)0.450.71 (0.24 to 2.10)0.541.69 (0.85 to 3.83)0.141.49 (0.70 to 3.15)0.30
Age0.97 (0.95 to 1.00)0.100.98 (0.94 to 1.03)0.421.00 (0.98 to 1.04)0.610.97 (0.93 to 0.99) 0.04
Specialty1.34 (0.77 to 2.35)0.311.30 (0.60 to 2.83)0.511.43 (0.82 to 2.50)0.201.59 (0.85 to 2.97)0.15
Clinical settings0.51 (0.30 to 0.86) 0.01 0.74 (0.36 to 1.50)0.401.55 (0.90 to 2.68)0.110.95 (0.52 to 1.73)0.86
Clinical experience1.33 (0.59 to 2.99)0.491.39 (0.45 to 4.31)0.570.94 (0.43 to 2.05)0.881.93 (0.81 to 4.61)0.14
Anaphylaxis diagnosisNANA5.65 (2.81 to 11.36) <0.01 0.73 (0.44 to 1.24)0.240.35 (0.19 to 0.67) <0.01